BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 19934659)

  • 41. Differences in the ubiquitination of p53 by Mdm2 and the HPV protein E6.
    Camus S; Higgins M; Lane DP; Lain S
    FEBS Lett; 2003 Feb; 536(1-3):220-4. PubMed ID: 12586367
    [TBL] [Abstract][Full Text] [Related]  

  • 42. NUB1 promotes cytoplasmic localization of p53 through cooperation of the NEDD8 and ubiquitin pathways.
    Liu G; Xirodimas DP
    Oncogene; 2010 Apr; 29(15):2252-61. PubMed ID: 20101219
    [TBL] [Abstract][Full Text] [Related]  

  • 43. COT phosphorylates prolyl-isomerase Pin1 to promote tumorigenesis in breast cancer.
    Kim G; Khanal P; Kim JY; Yun HJ; Lim SC; Shim JH; Choi HS
    Mol Carcinog; 2015 Jun; 54(6):440-8. PubMed ID: 24265246
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The prolyl isomerase Pin1 stabilizes the human T-cell leukemia virus type 1 (HTLV-1) Tax oncoprotein and promotes malignant transformation.
    Jeong SJ; Ryo A; Yamamoto N
    Biochem Biophys Res Commun; 2009 Apr; 381(2):294-9. PubMed ID: 19338781
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of peptidyl-prolyl isomerase 1 depletion in animal models of prion diseases.
    Legname G; Virgilio T; Bistaffa E; De Luca CMG; Catania M; Zago P; Isopi E; Campagnani I; Tagliavini F; Giaccone G; Moda F
    Prion; 2018 Mar; 12(2):127-137. PubMed ID: 29676205
    [TBL] [Abstract][Full Text] [Related]  

  • 46. RNF12 promotes p53-dependent cell growth suppression and apoptosis by targeting MDM2 for destruction.
    Gao K; Wang C; Jin X; Xiao J; Zhang E; Yang X; Wang D; Huang H; Yu L; Zhang P
    Cancer Lett; 2016 May; 375(1):133-141. PubMed ID: 26926424
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Trophoblastic p53 is stabilised by a cis-trans isomerisation necessary for the formation of high molecular weight complexes involving the N-terminus of p53.
    Cohen M; Wuillemin C; Bischof P
    Biochimie; 2008 Jun; 90(6):855-62. PubMed ID: 18316040
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Dual function of Pin1 in NR4A nuclear receptor activation: enhanced activity of NR4As and increased Nur77 protein stability.
    van Tiel CM; Kurakula K; Koenis DS; van der Wal E; de Vries CJ
    Biochim Biophys Acta; 2012 Oct; 1823(10):1894-904. PubMed ID: 22789442
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Acetylation-dependent regulation of MDM2 E3 ligase activity dictates its oncogenic function.
    Nihira NT; Ogura K; Shimizu K; North BJ; Zhang J; Gao D; Inuzuka H; Wei W
    Sci Signal; 2017 Feb; 10(466):. PubMed ID: 28196907
    [TBL] [Abstract][Full Text] [Related]  

  • 50. miR-100 antagonism triggers apoptosis by inhibiting ubiquitination-mediated p53 degradation.
    Yang G; Gong Y; Wang Q; Wang L; Zhang X
    Oncogene; 2017 Feb; 36(8):1023-1037. PubMed ID: 27524417
    [TBL] [Abstract][Full Text] [Related]  

  • 51. USP11 regulates p53 stability by deubiquitinating p53.
    Ke JY; Dai CJ; Wu WL; Gao JH; Xia AJ; Liu GP; Lv KS; Wu CL
    J Zhejiang Univ Sci B; 2014 Dec; 15(12):1032-8. PubMed ID: 25471832
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dual-site regulation of MDM2 E3-ubiquitin ligase activity.
    Wallace M; Worrall E; Pettersson S; Hupp TR; Ball KL
    Mol Cell; 2006 Jul; 23(2):251-63. PubMed ID: 16857591
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Allostery: DNA does it, too.
    Chaires JB
    ACS Chem Biol; 2008 Apr; 3(4):207-9. PubMed ID: 18422302
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Nuclear Tau, p53 and Pin1 Regulate PARN-Mediated Deadenylation and Gene Expression.
    Baquero J; Varriano S; Ordonez M; Kuczaj P; Murphy MR; Aruggoda G; Lundine D; Morozova V; Makki AE; Alonso ADC; Kleiman FE
    Front Mol Neurosci; 2019; 12():242. PubMed ID: 31749682
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pin1 is related with clinical stage of papillary thyroid carcinoma.
    Jiang L; Chu H; Zheng H
    World J Surg Oncol; 2016 Mar; 14():95. PubMed ID: 27029791
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The prolyl isomerase pin1 regulates mRNA levels of genes with short half-lives by targeting specific RNA binding proteins.
    Krishnan N; Titus MA; Thapar R
    PLoS One; 2014; 9(1):e85427. PubMed ID: 24416409
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Differential regulation of cellular senescence and differentiation by prolyl isomerase Pin1 in cardiac progenitor cells.
    Toko H; Hariharan N; Konstandin MH; Ormachea L; McGregor M; Gude NA; Sundararaman B; Joyo E; Joyo AY; Collins B; Din S; Mohsin S; Uchida T; Sussman MA
    J Biol Chem; 2014 Feb; 289(9):5348-56. PubMed ID: 24375406
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Gene expression modifications in Wharton's Jelly mesenchymal stem cells promoted by prolonged in vitro culturing.
    Gatta V; D'Aurora M; Lanuti P; Pierdomenico L; Sperduti S; Palka G; Gesi M; Marchisio M; Miscia S; Stuppia L
    BMC Genomics; 2013 Sep; 14():635. PubMed ID: 24053474
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pin1, a novel switch in the ubiquitin pathway.
    Jentsch S; Siepe D
    Cell Cycle; 2009 Dec; 8(23):3800-1. PubMed ID: 19934659
    [No Abstract]   [Full Text] [Related]  

  • 60. Prolyl isomerase Pin1 acts as a switch to control the degree of substrate ubiquitylation.
    Siepe D; Jentsch S
    Nat Cell Biol; 2009 Aug; 11(8):967-72. PubMed ID: 19597489
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.